CoreAge Rx, a leading telehealth pharmacy specializing in personalized medication services, today announced a strategic New Year's expansion of its compounded GLP-1 ...
The acceptance of the BBI-940 IND enables Boundless to advance the program into a first-in-human clinical trial for patients with metastatic breast cancer, KOMODO-1 (Kinesin Oral Molecular Degrader ...
A plan to slash Food and Drug Administration drug review times is raising alarms at the public health agency that's been ...
Fernando Mendoza arrived on Indiana’s campus last January carrying huge expectations for himself and the program. Outsiders ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback